## **Core Concept**
The use of nasal drops, especially for an extended period, can lead to adverse effects due to their pharmacological action on the nasal mucosa and the body's response to prolonged exposure. Nasal drops often contain sympathomimetic agents like phenylephrine or oxymetazoline, which cause vasoconstriction.

## **Why the Correct Answer is Right**
The correct answer, . (Rebound congestion or rhinitis medicamentosa), is right because prolonged use of nasal decongestants leads to rebound congestion. This occurs due to the phenomenon of **tachyphylaxis** and **downregulation** of receptors. With continuous use, the nasal mucosa becomes dependent on the decongestant to remain decongested. When the effect wears off, the mucosa congest more than before, leading to a cycle of increased usage and dependency.

## **Why Each Wrong Option is Incorrect**
- **Option A:** is incorrect because while nasal drops might have systemic effects, the direct and most common consequence of long-term use is local.
- **Option B:** is incorrect as there isn't a well-documented, direct association between long-term nasal drop use and the development of nasal polyps as a primary adverse effect.
- **Option C:** is incorrect because although infection is a risk with any invasive or disruptive medical intervention, it's not the most directly related or commonly emphasized risk with prolonged nasal drop use.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that **rhinitis medicamentosa** can be treated by stopping the offending agent and sometimes using **steroid nasal sprays** to help alleviate symptoms. Patients should be warned about the potential for rebound congestion with prolonged use of nasal decongestants.

## **Correct Answer:** . Rebound congestion or rhinitis medicamentosa